Targeted therapies in cancer: From clinic to labs

Professor. Frederique Penault-Llorca, CEO of the Comprehensive Regional Cancer Institute Centre Jean PERRIN, Clermont-Ferrand, France and Deputy President, UNICANCER, and Professor Pascal Pujol, Head of Cancer Genetics department at the University Hospital of Montpellier, France and President of the French Society of Predictive and Personalized Medicine (SFMPP) will discuss the topic of implementing targeted therapies in cancer from a European perspective.